425.17
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $425.17, with a volume of 1.24M.
It is up +2.15% in the last 24 hours and up +5.22% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$416.23
Open:
$422.46
24h Volume:
1.24M
Relative Volume:
0.75
Market Cap:
$92.33B
Revenue:
$200.42B
Net Income/Loss:
$5.24B
P/E Ratio:
18.09
EPS:
23.5042
Net Cash Flow:
$6.45B
1W Performance:
+4.16%
1M Performance:
+5.22%
6M Performance:
+14.70%
1Y Performance:
+24.80%
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health Inc
|
425.17 | 90.39B | 200.42B | 5.24B | 6.45B | 23.50 |
|
UNH
Unitedhealth Group Inc
|
429.09 | 385.62B | 449.71B | 12.81B | 19.67B | 13.24 |
|
CVS
Cvs Health Corp
|
105.90 | 132.89B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
CI
Cigna Group
|
304.50 | 77.63B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
406.00 | 47.09B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-26 | Initiated | Evercore ISI | In-line |
| Feb-03-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-21-25 | Downgrade | Argus | Buy → Hold |
| Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
AE1K Bond Profile — Key Metrics - TradingView
Will Health Benefits Weakness Drag Elevance's Q2 Earnings? - TradingView
Mizuho Adjusts Price Target on Elevance Health to $470 From $465, Maintains Outperform Rating - marketscreener.com
Wells Fargo Adjusts Price Target on Elevance Health to $492 From $391, Maintains Overweight Rating - marketscreener.com
Elevance Health's Q2 2026 earnings: What to expect - MSN
Elevance Health stock reflects the insurer's scale and diversified health benefits business - ad-hoc-news.de
Elevance Health: Defense For An Undervalued Price - Seeking Alpha
Should Elevance Health’s (ELV) Index Shift and Softer Outlook Require Action From Investors? - Yahoo Finance
St. Louis Alzheimer's diagnostics company lands first U.S. insurance coverage - The Business Journals
Is ELV's Capital Allocation Strategy Creating Long-Term Value? - TradingView
Can UNH's Lifestyle Spending Account Redefine Employee Benefits? - TradingView
Elevance Health stock steadies as investors await the next update - AD HOC NEWS
Wellpoint out as D.C. Medicaid provider; AmeriHealth Caritas D.C. taking over - The Business Journals
Elevance Health Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Anthem partners with 1si to lower cost of health coverage for small businesses - News and Tribune
Elevance Health stock: Is ELV underperforming the health care sector? - MSN
Elevance Health stock hits 52-week high at 427.49 USD By Investing.com - Investing.com India
Elevance Health stock hits 52-week high at 427.49 USD - Investing.com
Can Centene's Operational Execution Keep Margin Recovery on Track? - TradingView
RBC Adjusts Price Target on Elevance Health to $439 From $358, Maintains Sector Perform Rating - marketscreener.com
CADEN CAPITAL PARTNERS, LP's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health options suggest 5.6% move on July 15 earnings By Investing.com - Investing.com South Africa
Elevance Health options suggest 5.6% move on July 15 earnings - Investing.com
Analysts Estimate Elevance Health (ELV) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Elevance Health stock holds focus on its business model. - AD HOC NEWS
Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide - AOL.com
Elevance Sues CMS Over Star Ratings, Seeks Same Recalculation Applied to Clover - MedCity News
Form 144 Elevance Health For: 7 July By Investing.com - Investing.com Nigeria
[144] Elevance Health, Inc. SEC Filing - Stock Titan
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide - AOL.com
Cantor Fitzgerald Adjusts Elevance Health Price Target to $450 From $400 - Moomoo
Elevance Health Is Maintained at Overweight by Cantor Fitzgerald - Moomoo
Evercore ISI Adjusts Price Target on Elevance Health to $440 From $360 - Moomoo
Elevance Health highlights managed care strategy as investors track S&P 500 exposure - AD HOC NEWS
Elevance Health to discuss Q2FY26 results on July 15 - scanx.trade
Press Release: Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026 - Moomoo
Elevance Health shapes its insurance and benefits profile as investors weigh long-term growth - AD HOC NEWS
Elevance Health Inc. stock underperforms Monday when compared to competitors - MarketWatch
Elevance Health sets July 15 call on Q2 2026 results - Stock Titan
T. Rowe Price Global Allocation Fund's Elevance Health Inc(ELV) Holding History - GuruFocus
UnitedHealth Bets on Profitability Over Growth: Will It Pay Off? - TradingView
Can Centene's Fraud Prevention Strategy Support Margin Recovery? - TradingView
Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit - Benzinga
Elevance Health focuses on managed care growth and digital health strategy - AD HOC NEWS
Anthem Blue Cross and Blue Shield and USA TODAY Launch Video Series to Help Americans Navigate Health Care - Financial Times
Elevance Health, Inc. (ELV) Stock Analysis: Navigating a Solid Healthcare Play with a 0.85% Upside Potential - DirectorsTalk Interviews
T. Rowe Price Moderate Allocation Portfolio's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health focuses on managed care strategy as a major US insurer - AD HOC NEWS
ELVElevance Health Inc Latest SEC Filings - Finviz
Elevance Health (ELV) Sues CMS Over Medicare Ratings And Bonus Payment Rules - simplywall.st
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):